Purgo Biologics

Purgo Biologics Inc., founded in 1999, focuses on the research, development, production, and sales of safe biomaterials for dental soft tissue and bone regeneration. Through various clinical studies and collaborative research with governments, clinicians, and educational institutions, Purgo Biologics has developed a full range of dental soft tissue and bone regeneration biomaterial products that meet international quality standards. These include THE GraftTM bone graft material, OpernTex®️ non-resorbable collagen membrane, Biotex®️ PTFE sutures, and BioCover®️ resorbable collagen membrane. Its bone regeneration solutions have been registered in 41 countries and regions, including the EU, the United States, and Japan. Globally, these solutions are widely appreciated by dentists in both scientific research and clinical applications. Mr. Kang Ho Chang, the founder and a technical expert in the field of bone regeneration, has over a decade of experience in developing dental bone regeneration products and has published numerous articles related to xenogeneic bone graft materials.